성체줄기세포 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 제품 및 서비스별, 적응증별, 용도별, 최종 용도별, 부문별 예측(2024-2030년)

Adult Stem Cells Market Size & Trends

The global adult stem cells market size was valued at USD 12.35 billion in 2023 and is projected to grow at a CAGR of 11.2% from 2024 to 2030, driven by several key factors. These cells, found in various tissues and organs, hold immense potential for regenerative medicine and therapeutic applications. As research continues to uncover their capabilities, the market is poised for significant expansion in the coming years.Research and development (R&D) efforts in adult stem cell therapies have intensified, propelled by advances in biotechnology and molecular biology.

Scientists are exploring new sources of adult stem cells, optimizing culture techniques, and refining methods for differentiation into specialized cell types. For instance, Boston Children's Hospital has achieved significant milestones in adult stem cell research, including the isolation of lung stem cells from both normal lungs and those affected by lung cancer. These innovations are expanding the scope of potential applications in treating a wide range of diseases and injuries, from cardiovascular disorders to neurological conditions.

One of the most important drivers of the market is the increasing investment in research and development. Pharmaceutical companies, biotechnology firms, and academic institutions are allocating significant resources to explore the therapeutic potential of adult stem cells across various medical applications. For instance, the Department of Biotechnology (DBT) in India is actively supporting initiatives in many areas of stem cell research from 2019 to 2022. These initiatives include fundamental biological insights, translational research projects, and genetics conversion technologies for power and clinical applications. During this period, DBT committed USD 8.80 million to these projects. These investments support preclinical studies, clinical trials, and the development of scalable manufacturing processes.

Advanced technologies such as CRISPR-Cas9 gene editing and induced pluripotent stem cells (iPSCs) are enhancing researchers' ability to manipulate and utilize stem cells effectively. As R&D efforts yield promising results and regulatory frameworks evolve, the market is poised to expand, offering innovative solutions for treating complex diseases and improving patient outcomes globally.

In addition, the increasing prevalence of chronic diseases represents a significant driver of market growth. Conditions such as diabetes, cardiovascular diseases, and neurodegenerative disorders are rising due to aging populations and lifestyle factors. As per the February 2024 report released by the CDC, roughly 129 million individuals in the U.S. are impacted by at least one significant chronic illness. Adult stem cells offer potential therapies that can address the underlying causes of these diseases, providing regenerative solutions that traditional treatments often cannot match. As healthcare systems seek more effective and personalized approaches to managing chronic conditions, the demand for adult stem cell therapies is expected to grow, fueling further research, development, and adoption in clinical settings.

Furthermore, regulatory agencies worldwide are establishing guidelines to ensure the safety, efficacy, and ethical use of adult stem cell therapies. Streamlined approval processes and clearer regulatory pathways encourage investment in commercialization and market expansion, facilitating patient access to advanced treatment options.

Global Adult Stem Cells Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global adult stem cells market report based on type, product & services, indication, application, end use, and region.

• Type Outlook (Revenue, USD Billion, 2018 - 2030)
• Autologous Adult Stem Cells
• Allogeneic Adult Stem Cells
• Product & Services Outlook (Revenue, USD Billion, 2018 - 2030)
• Product

Kits, Media, & Reagents

Cells & cell lines

Hematopoietic

Mesenchymal

Neural

Epithelial/Skin

Others

Services

• Indication Outlook (Revenue, USD Billion, 2018 - 2030)
• Bone and Cartilage Repair
• Cardiovascular Diseases
• Inflammatory and Immunological Diseases
• Liver diseases
• Cancer
• GvHD
• Others
• Application Outlook (Revenue, USD Billion, 2018 - 2030)
• Therapeutics
• Disease Modeling
• Drug Development & Discovery
• Toxicology Studies
• Biobanking
• Tissue Engineering
• Others
• End Use Outlook (Revenue, USD Billion, 2018 - 2030)
• Biopharmaceutical Companies
• Research Institutes
• Hospitals & Clinics
• Regional Outlook (Revenue, USD Billion, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Norway

Denmark

Sweden

• Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

• Latin America

Brazil

Argentina

• Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Product & Services
  • 1.2.3. Indication
  • 1.2.4. Application
  • 1.2.5. End Use
  • 1.2.6. Regional Scope
  • 1.2.7. Estimates and forecasts timeline
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights

Chapter 3. Adult Stem Cells Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Adult stem cells market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Adult Stem Cells Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Adult stem cells market: Type Movement Analysis
• 4.3. Adult stem cells market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Autologous Adult Stem Cells
  • 4.5.1. Autologous Adult Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Allogeneic Adult Stem Cells
  • 4.6.1. Allogeneic Adult Stem Cells Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Adult Stem Cells Market: Product & Services Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Adult stem cells market: Product & Services Movement Analysis
• 5.3. Adult stem cells market by Product & Services Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Product
  • 5.5.1. Product Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. Kits, Media, & Reagents
    • 5.5.2.1. Kits, Media, & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Cells & Cell Lines
    • 5.5.3.1. Cells & Cell Lines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3.2. Hematopoietic

5.5.3.2.1. Hematopoietic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

• 5.5.3.3. Mesenchymal

5.5.3.3.1. Mesenchymal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

• 5.5.3.4. Neural

5.5.3.4.1. Neural Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

• 5.5.3.5. Epithelial/Skin

5.5.3.5.1. Epithelial/Skin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

• 5.5.3.6. Others

5.5.3.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

• 5.6. Services
  • 5.6.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Adult Stem Cells Market: Indication Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Adult stem cells market: Indication Movement Analysis
• 6.3. Adult stem cells market by Indication Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Bone and Cartilage Repair
  • 6.5.1. Bone and Cartilage Repair Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Cardiovascular Diseases
  • 6.6.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Inflammatory and Immunological Diseases
  • 6.7.1. Inflammatory and Immunological Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Liver Diseases
  • 6.8.1. Liver Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.9. Cancer
  • 6.9.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.10. GvHD
  • 6.10.1. GvHD Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.11. Others
  • 6.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Adult Stem Cells Market: Application Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Adult stem cells market: Application Movement Analysis
• 7.3. Adult stem cells market by Application Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Therapeutics
  • 7.5.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Disease Modeling
  • 7.6.1. Disease Modeling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Drug Development & Discovery
  • 7.7.1. Drug Development & Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Toxicology Studies
  • 7.8.1. Toxicology Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Biobanking
  • 7.9.1. Biobanking Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.10. Tissue Engineering
  • 7.10.1. Tissue Engineering Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.11. Others
  • 7.11.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Adult Stem Cells Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Adult stem cells market: End Use Movement Analysis
• 8.3. Adult stem cells market by End Use Outlook (USD Million)
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 8.5. Biopharmaceutical Companies
  • 8.5.1. Biopharmaceutical Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Research Institutes
  • 8.6.1. Research Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Hospitals & Clinics
  • 8.7.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Adult Stem Cells Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Regional Adult stem cells market movement analysis
• 9.3. Adult stem cells market: Regional Estimates & Trend Analysis by Type, Product & Services & End-use
• 9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 9.5. North America
  • 9.5.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. U.S.
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. Canada
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.4. Mexico
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Europe
  • 9.6.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. UK
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. Germany
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Competitive scenario
    • 9.6.3.3. Regulatory framework
    • 9.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. France
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Competitive scenario
    • 9.6.4.3. Regulatory framework
    • 9.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Italy
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Competitive scenario
    • 9.6.5.3. Regulatory framework
    • 9.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.6. Spain
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Competitive scenario
    • 9.6.6.3. Regulatory framework
    • 9.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.7. Denmark
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Competitive scenario
    • 9.6.7.3. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.8. Sweden
    • 9.6.8.1. Key country dynamics
    • 9.6.8.2. Competitive scenario
    • 9.6.8.3. Regulatory framework
    • 9.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.9. Norway
    • 9.6.9.1. Key country dynamics
    • 9.6.9.2. Competitive scenario
    • 9.6.9.3. Regulatory framework
    • 9.6.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. Asia Pacific
  • 9.7.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. Japan
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. China
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.4. India
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.5. Australia
    • 9.7.5.1. Key country dynamics
    • 9.7.5.2. Competitive scenario
    • 9.7.5.3. Regulatory framework
    • 9.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.6. South Korea
    • 9.7.6.1. Key country dynamics
    • 9.7.6.2. Competitive scenario
    • 9.7.6.3. Regulatory framework
    • 9.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.7. Thailand
    • 9.7.7.1. Key country dynamics
    • 9.7.7.2. Competitive scenario
    • 9.7.7.3. Regulatory framework
    • 9.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.8. Latin America
  • 9.8.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.2. Brazil
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Competitive scenario
    • 9.8.2.3. Regulatory framework
    • 9.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.3. Argentina
    • 9.8.3.1. Key country dynamics
    • 9.8.3.2. Competitive scenario
    • 9.8.3.3. Regulatory framework
    • 9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.9. MEA
  • 9.9.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.2. South Africa
    • 9.9.2.1. Key country dynamics
    • 9.9.2.2. Competitive scenario
    • 9.9.2.3. Regulatory framework
    • 9.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.3. Saudi Arabia
    • 9.9.3.1. Key country dynamics
    • 9.9.3.2. Competitive scenario
    • 9.9.3.3. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.4. UAE
    • 9.9.4.1. Key country dynamics
    • 9.9.4.2. Competitive scenario
    • 9.9.4.3. Regulatory framework
    • 9.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9.5. Kuwait
    • 9.9.5.1. Key country dynamics
    • 9.9.5.2. Competitive scenario
    • 9.9.5.3. Regulatory framework
    • 9.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Key Company Market Position Analysis, 2023
• 10.3. Key Company Profiles
  • 10.3.1. Thermo Fisher Scientific, Inc
    • 10.3.1.1. Company overview
    • 10.3.1.2. Financial performance
    • 10.3.1.3. Product benchmarking
    • 10.3.1.4. Strategic initiatives
  • 10.3.2. STEMCELL Technologies
    • 10.3.2.1. Company overview
    • 10.3.2.2. Financial performance
    • 10.3.2.3. Product benchmarking
    • 10.3.2.4. Strategic initiatives
  • 10.3.3. Osiris Therapeutics
    • 10.3.3.1. Company overview
    • 10.3.3.2. Financial performance
    • 10.3.3.3. Product benchmarking
    • 10.3.3.4. Strategic initiatives
  • 10.3.4. ZenBio, Inc.
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Product benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. Stempeutics Research
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Product benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Fate Therapeutics, Inc.
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Product benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. BrainStorm Cell Therapeutics Inc.
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Product benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Celgene Corporation
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Product benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. Stemedica Cell Technologies, Inc.
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Product benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. Vericel Corporation
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Product benchmarking
    • 10.3.10.4. Strategic initiatives